Partners

If you order whole exomes or whole genomes, we'd love to hear from you. Lodestar is particularly focused on pediatric rare disease, but we're able to reinterpret any inconclusive exome or genome.

If you want to learn more or have specific questions, send us a message.

Lodestar is actively looking for new interpretation partners who want to help provide rare disease patients with a diagnosis. We're tackling some of the most unique and difficult cases in the world. We need deep, differentiated expertise. Get in touch if your company has:

• The ability to interpret structural variants missed by other tools.

• Unique insights into non-coding variation.

• An AI pipeline that makes connections between complex phenotypes and genotypes.

At Lodestar, we recognize that diagnosing rare disease is a beginning as much as it's an end. That's why we're committed to helping find promising new solutions for our patients. If you're a biopharma company that would like to learn more about Lodestar's early-stage target and therapeutic discovery pipeline, please feel free to contact us.